Related Experiment Video
Updated: Dec 11, 2025

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
Published on: April 18, 2025
18F-Florbetapir PET in Primary Cerebral Amyloidoma
Frederik Soffers1, Sarah Ceyssens1, Wendi Buffet2
1From the Department of Nuclear Medicine, University Hospital of Antwerp.
Abstract:
Amyloid deposition can lead to Alzheimer disease and cerebral amyloid angiopathy. Rarely, it presents as a solitary focal deposition, primary cerebral amyloidoma, which can be misinterpreted as a neoplasm because of the "tumor-like" appearances. We present the case of a 54-year-old woman where MRI revealed a T2-hyperintense mass periventricular in the white matter with moderate contrast enhancement. Pathological investigation revealed AL (lambda) amyloidoma. F-florbetapir PET/CT was used to support the diagnosis and in follow-up. This case highlights that F-florbetapir PET/CT might play a role in the diagnostic workup of patients suggestive of cerebral amyloidoma, especially in cases where biopsy is not feasible.
Insights
Primary cerebral amyloidoma, a rare focal amyloid deposition, can mimic tumors. F-florbetapir PET/CT aids in diagnosing this condition, especially when biopsy is not possible.
Area of Science:
- Neuropathology
- Neuroradiology
- Nuclear Medicine
Background:
- Amyloid deposition is linked to Alzheimer disease and cerebral amyloid angiopathy.
- Primary cerebral amyloidoma is a rare focal deposition that can present as a tumor-like lesion.
- Misdiagnosis as a neoplasm is a concern due to similar imaging characteristics.
Observation:
- A 54-year-old woman presented with a periventricular white matter mass on MRI.
- The mass showed T2-hyperintensity and moderate contrast enhancement.
- Pathological investigation confirmed AL (lambda) amyloidoma.
Findings:
- F-florbetapir PET/CT was utilized for diagnostic support and patient follow-up.
- The imaging findings were consistent with amyloid deposition.
- This case demonstrates the utility of F-florbetapir PET/CT in identifying amyloidoma.
Implications:
- F-florbetapir PET/CT may be a valuable tool in the diagnostic workup of suspected cerebral amyloidoma.
- This imaging modality is particularly useful in cases where biopsy is not feasible.
- Improved diagnostic accuracy can lead to appropriate management and reduce unnecessary interventions for suspected neoplasms.
More Related Videos
09:03Radiotracer Administration for High Temporal Resolution Positron Emission Tomography of the Human Brain: Application to FDG-fPET
Published on: October 22, 2019
10:02Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography FDG-PET/CT
Published on: May 2, 2012
Related Concept Videos
Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET